Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review

Author:

Mathew Christo1,Patel Ankur1,Cholankeril George12,Flores Avegail13,Hernaez Ruben13

Affiliation:

1. Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA

2. Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Baylor St. Luke’s Medical Center, Houston, Texas, USA

3. Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine and Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA

Abstract

Abstract Background: Cardiovascular disease commonly affects advanced liver disease patients. They undergo cardiac interventions to improve cardiac outcomes. Cirrhosis increases complication risk, including bleeding, renal and respiratory failure, and further decompensation, including death, posing a clinical dilemma to proceduralists. Predicting outcomes is crucial in managing patients with cirrhosis. Our aim was to systematically review clinical parameters to assess the mortality and complication risk in patients with cirrhosis undergoing cardiac interventions. Methods: We searched cirrhosis and cardiovascular intervention terminology in PubMed and Excerpta Medica Database (EMBASE) from inception to January 8, 2023. We included studies reporting clinical scores (e.g. Model for End-stage Liver Disease (MELD), Child–Pugh–Turcotte (CPT), cardiovascular interventions, mortality, and morbidity outcomes). We independently abstracted data from eligible studies and performed qualitative summaries. Results: Eight studies met the inclusion criteria. Procedures included tricuspid valve surgery, catheterization-related procedures, aortic valve replacement (AVR), pericardiectomy, and left ventricular assist device (LVAD) placement. MELD primarily predicted mortality (n = 4), followed by CPT (n = 2). Mortality is significantly increased for MELD > 15 after tricuspid valve surgery. Albumin, creatinine, and MELD were significantly associated with increased mortality after transcatheter AVR (TAVR), although specific values lacked stratification. CPT was significantly associated with increased mortality after cardiac catheterization or pericardiectomy. In LVAD placement, increasing MELD increased the unadjusted odds for perioperative mortality. Conclusions: Our systematic review showed that clinical parameters predict mortality and morbidity risk in patients with cirrhosis undergoing cardiac procedures.

Publisher

Medknow

Subject

Gastroenterology

Reference18 articles.

1. NAFLD as a continuum:From obesity to metabolic syndrome and diabetes;Godoy-Matos;Diabetol Metab Syndr,2020

2. Ischemic heart disease and liver cirrhosis:Adding insult to injury;Gîrleanu;Life (Basel),2022

3. Helpfulness of the liver disease scores in cardiac surgery for cirrhotic patients;Sebestyen;Gen Thorac Cardiovasc Surg,2022

4. Complication rates after cardiac catheterization in patients with cirrhosis:246;Narang;Am J Gastroenterol,2010

5. Cardiac catheterization in patients with end-stage liver disease:Safety and outcomes;Pillarisetti;Catheter Cardiovasc Interv,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3